Single-Arm Study to Assess the Efficacy of UVADEX (Methoxsalen) Sterile Solution in Conjunction With the THERAKOS CELLEX Photopheresis System in Pediatric Patients With Steroid-Refractory Acute Graft-vs-Host Disease (aGvHD)

Status: Discontinued

Phase of Trial: Phase III

Latest Information Update: 24 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Methoxsalen (Primary)
Indications Graft-versus-host disease
Focus Therapeutic Use
Sponsors Mallinckrodt Inc.; Therakos

Most Recent Events

01 May 2022 Results assessing the efficacy and safety of a single-device ECP system in children with SR-aGVHD published in the Transplantation and Cellular Therapy
18 Dec 2021 This trial has been completed in Italy (End Date: 16 Jul 2019), according to European Clinical Trials Database record.
31 Jul 2021 This trial has been completed in spain (End Date: 16 Jul 2019) according to European Clinical Trials Database.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight